Access to Medications
When the federal election was called in 2005, everything was pretty quiet on the Cross Border Internet Pharmacy issue in Canada. Then came the mid term elections in the U.S.
Recommendations that focus on prescribing older drugs to curb overspending focuses on costs first and the patient last.
While many of the general principles outlined in the report are seen as positive, the report falls short in identifying specific policy options which will support the delivery of full and equitable access to medications for all Canadians.
People living in provinces outside Central Canada delight in accusing Ontarians of believing that what happens in Ontario affects the entire country – that Ontario is the “center of the universe.” This time, however, it could be true. Profound and innovative changes to the Ontario Drug Benefit Act could be the catalyst for policy changes throughout the country.
What meds do you store in your carrion?
Canada's National Pharmaceutical Strategy (NPS) is off to a shaky start. Two years of clandestine meetings have kept the Canadian public in the dark and stakeholders scratching their heads. Who are these people and what are they doing?
A study from the Queen Elizabeth Hospital in Birmingham has highlighted a hitherto overlooked source of the killer super-bug MRSA
Pharmaceutical policy is central to the sustainability of not only national pharmacare programs, but the long-term stability of health care systems as a whole. But what do Canadians know and understand about the National Pharmaceutical Strategy and the government's plans.
CAPA members are invited to take a learning journey through the vocabulary and treatment protocols of the Superbug world.
This year has seen more meaningful patient involvement in Health Canada policy issues than ever before. We were involved as equal partners on the Expert Advisory Panel on Cox-2, in developing guidelines for a National Pharmaceutical Strategy, and consulted on cross border Internet pharmacy. It feels good. But don’t be fooled.